Publication | Closed Access

Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients

Cell TherapyPreemptive TherapyTransplantationCytomegalovirus InfectionStem Cell TransplantationImmunologyHematologyVirologyGraft SurvivalBlood TransplantationDnaemia CutoffMedicineCell Transplantation